Vevo Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Vevo Therapeutics's estimated annual revenue is currently $2.4M per year.
- Vevo Therapeutics's estimated revenue per employee is $77,500
Employee Data
- Vevo Therapeutics has 31 Employees.
- Vevo Therapeutics grew their employee count by 29% last year.
Vevo Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CSO & Co Founder | Reveal Email/Phone |
2 | Co Founder | Reveal Email/Phone |
3 | Head Operations | Reveal Email/Phone |
4 | Machine Learning Research Scientist | Reveal Email/Phone |
5 | Research Scientist - Mosaic Platform Lead | Reveal Email/Phone |
6 | Computational Biologist | Reveal Email/Phone |
7 | Research Scientist | Reveal Email/Phone |
8 | Senior Software Engineer | Reveal Email/Phone |
9 | Bioinformatics and ML scientist | Reveal Email/Phone |
10 | Principal ML Scientist | Reveal Email/Phone |
Vevo Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Vevo Therapeutics?
Vevo Therapeutics is a biotechnology company using its in vivo drug discovery platform and next generation AI models to uncover better drugs for more patients. The company’s Mosaic platform is the first to make in vivo data generation scalable, with single-cell precision, to capture in vivo context of disease at the first step of drug discovery and to better represent patient diversity in drug response over current in vitro assays. Vevo is using Mosaic to build the world’s largest in vivo atlas of how drugs interact with patient cells and training AI models on its data to find novel targets and drugs undetectable by other technologies. Located in San Francisco, CA, Vevo was founded by a team of inventors and thought leaders who have discovered drugs for “undruggable” targets and invented novel methods in genomics, computational biology, and chemistry. Vevo is backed by leading investors at the intersection of life sciences and technology, including General Catalyst, Wing Venture Capital, Mubadala Capital, AIX Ventures, and Camford Capital. Learn more at www.vevo.ai.
keywords:N/AN/A
Total Funding
31
Number of Employees
$2.4M
Revenue (est)
29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.7M | 31 | 7% | N/A |
#2 | $3.6M | 31 | -14% | N/A |
#3 | $4.5M | 31 | -14% | N/A |
#4 | $6.7M | 31 | -11% | N/A |
#5 | $6.7M | 31 | 3% | N/A |